9.1 Cardiovascular Chronic Disease Management (CHF, Hypertension & CAD)

9.1 Cardiovascular Chronic Disease Management (CHF, Hypertension & CAD)

Quick Summary: Cardiovascular disease represents the primary driver of 30-day hospital readmissions, emergency department recidivism, and chronic morbidity encountered by Community Paramedics within Domain 3 (Patient/Client Centric Care). Effective mobile integrated chronic care requires mastering the hemodynamic divergence between HFrEF and HFpEF, staging disease progression via ACC/AHA versus NYHA criteria, conducting rigorous physical exams for subclinical volume overload, enforcing daily weight protocols and dietary sodium/fluid restrictions, verifying adherence to the four mortality-reducing pillars of Guideline-Directed Medical Therapy (GDMT), stratifying hypertensive urgency versus emergency, and preserving Dual Antiplatelet Therapy (DAPT) compliance post-coronary stenting.

Cardiovascular chronic conditions rarely destabilize without warning. In the outpatient home setting, acute decompensated heart failure (ADHF), hypertensive crises, and recurrent ischemic events are preceded by days to weeks of physiological derangements, subtle fluid accumulation, dietary indiscretions, or medication non-adherence. The Community Paramedic acts as a proactive diagnostic and therapeutic bridge, identifying subclinical decompensation inside the patient's living environment before emergency rescue intervention becomes unavoidable.

---

Heart Failure Pathophysiology: HFrEF vs. HFpEF

Heart failure is a complex clinical syndrome resulting from structural or functional impairment of ventricular filling or blood ejection. Modern clinical cardiology classifies heart failure into two primary hemodynamic phenotypes based on the Left Ventricular Ejection Fraction (LVEF):

---

Staging and Classification: ACC/AHA Stages vs. NYHA Classes

A critical competency for the Community Paramedic is understanding the dual classification framework utilized in chronic heart failure. The American College of Cardiology / American Heart Association (ACC/AHA) stages describe the structural, progressive trajectory of the disease, whereas the New York Heart Association (NYHA) functional classes quantify subjective functional limitations and symptom severity at a specific point in time.

ACC/AHA STAGING (Structural, Progressive, Unidirectional)
[Stage A] ──► [Stage B] ──► [Stage C] ──► [Stage D]
At Risk        Pre-HF       Symptomatic   Refractory / End-Stage
(HTN, DM)     (Low LVEF,    Heart Failure (Requires inotropes,
              no symptoms)  (Prior/Current LVAD, transplant,
                            symptoms)     or hospice care)
                                 │
                                 ▼
NYHA FUNCTIONAL CLASSIFICATION (Subjective, Symptomatic, Bidirectional)
┌───────────────┬───────────────┬───────────────┬───────────────┐
│    Class I    │   Class II    │   Class III   │   Class IV    │
│ No functional │ Mild dyspnea  │ Marked limit; │ Symptoms at   │
│ limitations   │ with ordinary │ comfortable   │ rest or with  │
│ with exertion │ daily tasks   │ only at rest  │ minimal task  │
└───────────────┴───────────────┴───────────────┴───────────────┘

The ACC/AHA Structural Stages (Stages A through D)

• Stage A (At Risk for Heart Failure): Patients without structural heart disease or symptoms, but possessing high-risk conditions such as hypertension, diabetes, atherosclerotic cardiovascular disease, metabolic syndrome, or cardiotoxic medication exposure.
• Stage B (Pre-Heart Failure): Patients with structural heart disease (e.g., left ventricular hypertrophy, prior myocardial infarction, silent chamber enlargement, or asymptomatic reduced LVEF ≤ 40%) or elevated cardiac biomarkers (BNP/NT-proBNP), but who have never displayed symptoms of heart failure.
• Stage C (Symptomatic Heart Failure): Patients with structural heart disease who have current or previous symptoms of heart failure (e.g., dyspnea, fatigue, orthopnea, fluid retention). Crucial clinical rule: Once a patient develops symptoms and enters Stage C, they remain Stage C indefinitely, even if their symptoms completely resolve on medical therapy!
• Stage D (Advanced / Refractory Heart Failure): Patients with end-stage structural disease exhibiting marked refractory symptoms at rest despite maximal Guideline-Directed Medical Therapy. These patients experience recurrent hospital admissions and require advanced specialized interventions (mechanical circulatory support / LVAD, continuous intravenous inotrope infusions, cardiac transplantation, or palliative hospice care).

The NYHA Functional Classes (Classes I through IV)

Unlike ACC/AHA staging, NYHA functional classes are dynamic and move bidirectionally based on volume status, adherence, and pharmacological titration:

• Class I: No limitation of physical activity. Ordinary physical exertion (e.g., climbing two flights of stairs, carrying groceries) does not provoke excessive fatigue, palpitation, or dyspnea.
• Class II: Slight limitation of physical activity. Comfortable at rest, but ordinary physical exertion results in fatigue, palpitations, or shortness of breath.
• Class III: Marked limitation of physical activity. The patient remains comfortable at rest, but less-than-ordinary physical exertion (e.g., walking across a room, getting dressed, showering) produces severe dyspnea and exhaustion.
• Class IV: Inability to carry on any physical activity without discomfort. Symptoms of heart failure (dyspnea, chest tightness, orthopnea) are present even at complete rest. Any physical exertion increases discomfort.

---

Recognizing Early Volume Overload: The Home Physical Exam

Hospital admissions for heart failure are predominantly triggered by volume overload rather than acute contractile failure. Left ventricular filling pressures often rise 2 to 3 weeks before the patient notices overt dyspnea. Community Paramedics conduct systematic physical examinations to identify hypervolemia in its earliest subclinical phases:

1. Cardinal Symptoms of Congestion

• Orthopnea: Dyspnea occurring in the recumbent position, caused by the redistribution of pooled peripheral blood from the lower extremities and splanchnic circulation into the central thoracic circulation, elevating pulmonary capillary wedge pressures. Quantified by asking the patient: 'How many pillows do you sleep on to breathe comfortably?' or 'Have you moved from your bed to sleep upright in an armchair or recliner?'
• Paroxysmal Nocturnal Dyspnea (PND): Severe, terrifying episodes of sudden breathlessness and coughing that awaken the patient from sleep 1 to 2 hours after lying down. PND results from the slow interstitial reabsorption of dependent edema fluid into the intravascular compartment while recumbent, overwhelming impaired left ventricular handling. Unlike orthopnea, which improves immediately upon sitting up, PND requires 15 to 30 minutes of sitting upright at the bedside to achieve symptomatic relief.

2. Objective Hemodynamic & Physical Signs

• Jugular Venous Distension (JVD): The internal jugular vein reflects right atrial pressure (Central Venous Pressure). Position the patient semi-recumbent with the head of the examination surface elevated at 45°. Identify the highest point of internal jugular venous pulsation. Measure the vertical distance in centimeters between this pulsation peak and the sternal angle of Louis. A vertical height > 3–4 cm above the sternal angle (equating to a total CVP > 8–9 cm H₂O when adding the 5 cm distance from the sternal angle to the right atrium) indicates elevated right ventricular filling pressures and systemic hypervolemia.
• Hepatojugular Reflux (Abdominojugular Test): Apply steady, firm pressure with the flat of the hand over the patient's right upper quadrant (liver) or mid-abdomen for 10 to 15 seconds while observing the jugular venous pulsation. A sustained, persistent elevation of JVD > 3–4 cm throughout the duration of compression represents a positive test, confirming elevated right ventricular end-diastolic pressure and low right ventricular compliance.
• Pulmonary Auscultation (Bibasilar Crackles / Rales): Fine, dry, end-inspiratory crackles starting at the lung bases reflect transudation of fluid into the pulmonary alveoli. In chronic heart failure, extensive lymphatic clearance can mask crackles even in the presence of severely elevated pulmonary pressures; therefore, the absence of crackles does not rule out volume overload!
• Peripheral Pitting Edema: Quantified by applying firm thumb pressure over the anterior tibial crest and medial malleolus for 5 seconds. Graded from 1+ (2 mm indentation with instantaneous rebound) to 4+ (8 mm indentation lasting 2 to 5 minutes with gross dependent disfigurement). In bed-bound patients, dependent edema manifests over the sacrum and posterior thighs rather than the ankles.

---

Daily Weight Protocols & Dietary Restrictions

Daily weight tracking provides the single most sensitive, cost-effective early warning system for volume accumulation. Interstitial fluid volume increases by 3 to 5 liters (equivalent to 6 to 11 pounds) before physical pitting edema becomes clinically detectable.

The 'Rule of 2s and 5s' Daily Weight Action Plan

The Community Paramedic educates the client and caregiver on the standardized weight trigger protocol:

$\text{Action Threshold} = \mathbf{2\text{ to }3\text{ lb}\text{ (0.9–1.4 kg) overnight}} \quad \mathbf{OR} \quad \mathbf{5\text{ lb}\text{ (2.3 kg) in one week}}$

• Weighing Protocol Rules:
  1. Weigh every single morning immediately upon awakening.
  2. Weigh after the first morning urination and before eating breakfast or drinking liquids.
  3. Use the same calibrated digital scale placed on a hard, level, uncarpeted floor.
  4. Wear the same minimal clothing (or undressed) each day.
  5. Document daily weights in an accessible logbook or remote patient monitoring (RPM) cellular portal.
  6. If a weight gain of ≥ 2–3 lb overnight or ≥ 5 lb in 7 days occurs, the patient or paramedic must execute the pre-arranged medical action plan (e.g., contact the community paramedic or cardiology care team, verify adherence, and adjust oral diuretic dosing as protocolized).

Dietary Sodium and Fluid Restrictions

• Sodium Restriction: Prescribe and reinforce a dietary intake of < 2,000 mg of sodium per day (approximately 1 teaspoon of table salt across all meals) for symptomatic heart failure, tightened to < 1,500 mg/day in refractory Stage D disease. The paramedic inspects the patient's refrigerator and pantry, identifying hidden sodium in canned soups, processed meats, frozen dinners, condiments, and boxed foods.
• Fluid Restriction: Fluid restriction to 1.5 to 2.0 liters per day (50 to 68 fluid ounces) is indicated in patients with persistent hypervolemia or significant dilutional hyponatremia (serum sodium < 130 mEq/L). The clinician assists the client in establishing visual measurement systems (e.g., filling a 2-liter pitcher with water each morning to track daily liquid allowance across water, coffee, juice, and ice chips).

---

Guideline-Directed Medical Therapy (GDMT): The Four Pillars

Modern management of HFrEF mandates early, simultaneous initiation and stepwise up-titration of four pharmacologic classes known collectively as the Four Pillars of GDMT. Each pillar independently reduces all-cause mortality, cardiovascular death, and heart failure hospitalizations:

[!IMPORTANT] The Role of Loop Diuretics: Furosemide (Lasix), bumetanide (Bumex), and torsemide are essential symptomatic agents used to maintain euvolemia and relieve congestion. However, loop diuretics do NOT reduce mortality in heart failure! Overzealous diuresis activates the renin-angiotensin-aldosterone system (RAAS), worsening neurohormonal toxicity and precipitating prerenal azotemia.

---

Hypertension: Classification and Crisis Stratification

Community Paramedics encounter severe blood pressure elevations during home visits. Applying the 2017 ACC/AHA Hypertension Guidelines ensures accurate clinical staging and safe escalation:

ACC/AHA BLOOD PRESSURE CATEGORIES
┌───────────────────────┬───────────────────────┬───────────────────────┐
│ Category              │ Systolic BP (mmHg)    │ Diastolic BP (mmHg)   │
├───────────────────────┼───────────────────────┼───────────────────────┤
│ Normal                │ < 120                 │ and < 80              │
│ Elevated              │ 120–129               │ and < 80              │
│ Stage 1 Hypertension  │ 130–139               │ or 80–89              │
│ Stage 2 Hypertension  │ ≥ 140                 │ or ≥ 90               │
│ Hypertensive Crisis   │ > 180                 │ and/or > 120          │
└───────────────────────┴───────────────────────┴───────────────────────┘

Hypertensive Urgency vs. Hypertensive Emergency

When systolic BP exceeds 180 mmHg and/or diastolic BP exceeds 120 mmHg, the paramedic must immediately stratify the crisis based on the presence of acute target-organ damage:

Best Practices for Home Blood Pressure Monitoring

Accurate blood pressure measurement in the home requires adherence to strict standardized protocols:

1. The patient must sit quietly for at least 5 minutes before measurement.
2. Feet must be resting flat on the floor; legs uncrossed; back firmly supported.
3. The arm must be resting on a table supported at heart level (mid-sternum).
4. Ensure correct cuff bladder sizing: the bladder length must encircle 75–100% of the arm circumference, and width must equal at least 40% of arm circumference. A cuff that is too small falsely elevates BP readings!
5. No talking, caffeine consumption, exercise, or nicotine use for 30 minutes prior to measurement.

---

Coronary Artery Disease & Dual Antiplatelet Therapy (DAPT) Compliance

Community Paramedics frequently manage patients following percutaneous coronary intervention (PCI) with stent placement. Stable angina is distinguished from Acute Coronary Syndrome (ACS) by predictability: stable angina presents with substernal chest discomfort of consistent intensity, duration, and precipitating factors (exertion, stress), predictably relieved within 5 minutes by rest or sublingual nitroglycerin. ACS (unstable angina, NSTEMI, STEMI) presents as new-onset pain, angina at rest lasting > 20 minutes, or a crescendo pattern of escalating severity.

Critical DAPT Compliance Post-Stent

Placement of a drug-eluting stent (DES) disrupts coronary vascular endothelium. Until the stent struts are fully endothelialized (covered by native vascular tissue), bare metal exposure initiates rapid platelet adhesion, activation, and thrombosis. Patients require Dual Antiplatelet Therapy (DAPT) comprising:

1. Aspirin (81 mg daily indefinitely).
2. P2Y12 Receptor Inhibitor (Clopidogrel 75 mg daily, Ticagrelor 90 mg BID, or Prasugrel 10 mg daily) for a minimum of 6 to 12 months post-PCI.

[!CAUTION] Catastrophic Stent Thrombosis: Premature discontinuation of DAPT is the single greatest predictor of subacute stent thrombosis, which carries a 30–50% acute mortality rate from massive transmural myocardial infarction! Community Paramedics must verify that patients do not discontinue their P2Y12 inhibitor before minor dental work, elective procedures, or due to out-of-pocket prescription costs without direct clearance from their interventional cardiologist.

---

Step-by-Step Worked Clinical Scenario

Setting: A Community Paramedic performs a scheduled post-discharge home visit on a 71-year-old male enrolled in a heart failure reduction program 4 days after hospitalization for HFrEF (LVEF 28%).

• Subjective Assessment: The patient states he 'feels alright' but notes mild sleep disruption, having slept on 3 pillows rather than his baseline of 1. He reports consuming a bowl of canned chicken noodle soup the previous evening because he was too tired to cook.
• Objective Physical Exam:
  • Vital Signs: BP 134/82 mmHg, HR 74 bpm regular, RR 18 breaths/min, SpO₂ 94% on room air, Temp 98.4°F.
  • Weight: 186.4 lb (84.5 kg). Baseline dry discharge weight was 182.0 lb (82.5 kg). This represents a 4.4 lb weight gain in 72 hours.
  • Neck: Internal jugular venous pulsation observed 5 cm above the sternal angle at 45° (elevated JVD). Positive hepatojugular reflux sustained for 15 seconds.
  • Lungs: Faint end-inspiratory crackles at bilateral posterior lung bases that do not clear with coughing.
  • Extremities: 2+ pitting pretibial edema bilaterally.
  • Heart: S1, S2, and a distinct low-pitched S3 gallop audible at the apex.
• Clinical Decision & Execution:
  1. The paramedic identifies early Stage C, NYHA Class II–III hypervolemic decompensation triggered by dietary sodium indiscretion (canned soup contains ~1,800 mg sodium per serving).
  2. The clinician accesses collaborative medical direction via the cardiology care protocol. Because the patient is hemodynamically stable without respiratory distress, hypoperfusion, or acute chest pain, emergent 911 transport is not indicated.
  3. With physician authorization, the oral loop diuretic is adjusted: the patient's furosemide dose is doubled from 40 mg PO to 80 mg PO for 48 hours.
  4. The paramedic reviews the pantry, educates the patient on sodium label reading, reinforces the 1,500 mg daily sodium and 2-liter fluid limits, and schedules a repeat home visit in 24 hours to re-evaluate daily weight and renal status.

---

Common Exam Traps & Avoidance Strategies

1. Confusing ACC/AHA Stages with NYHA Classes: Remember that ACC/AHA stages are structural and strictly progressive (a patient cannot move backward from Stage C to Stage B, even if they become completely asymptomatic). NYHA classes are functional and move bidirectionally based on volume status and medication response.
2. Assuming Loop Diuretics Reduce Mortality: Diuretics (furosemide, bumetanide, torsemide) relieve hypervolemic symptoms but do not decrease mortality. If an exam question asks which agent improves survival in HFrEF, select one of the four pillars (ARNI/ACEi, beta-blocker, MRA, SGLT2i), not a loop diuretic.
3. Omitting the 36-Hour Washout Period: When switching a patient from an ACE inhibitor (e.g., lisinopril) to an ARNI (sacubitril/valsartan), a strict 36-hour washout interval is mandatory to prevent massive bradykinin accumulation and fatal angioedema. Switching between an ARB and an ARNI does not require this washout.
4. Overly Rapid BP Reduction in Hypertensive Urgency: Dropping blood pressure rapidly with sublingual nifedipine or aggressive intravenous agents in hypertensive urgency is contraindicated because it induces cerebral ischemia and watershed strokes. BP should be lowered gradually with oral medications over 24 to 48 hours.